Loading...

Protein Arginine Methyltransferase 5 as a Therapeutic Target for <i>KRAS</i> Mutated Colorectal Cancer

Nearly 45% of colorectal cancer (CRC) patients harbor a mutation in their <i>KRAS</i> gene for which, despite many years of research, there are still no targeted therapies available. Protein Arginine Methyltransferase 5 (PRMT5) is a transcription regulator for multiple cellular processes...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: David Shifteh, Tzuriel Sapir, Moshe Pahmer, Adam Haimowitz, Sanjay Goel, Radhashree Maitra
Format: Artigo
Sprog:Inglês
Udgivet: MDPI AG 2020-07-01
Serier:Cancers
Fag:
CRC
Online adgang:https://www.mdpi.com/2072-6694/12/8/2091
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!